OM:CAMX
OM:CAMXPharmaceuticals

Camurus (OM:CAMX) Valuation Check After New Long‑Acting Hypoparathyroidism Collaboration with Gubra

Camurus (OM:CAMX) just signed an exclusive collaboration and license deal with Danish biotech Gubra to develop a long acting treatment for hypoparathyroidism, a move that could quietly reshape its long term growth story. See our latest analysis for Camurus. The market seems to be pausing to reassess Camurus after a strong multi year run. The 90 day share price return of negative 13.19 percent contrasts with an impressive five year total shareholder return of 223.11 percent, suggesting long...
OM:BOL
OM:BOLMetals and Mining

The Bull Case For Boliden (OM:BOL) Could Change Following Aitik Tailings-Management Upgrades – Learn Why

ABB has recently upgraded the electrification and automation systems at Boliden’s Aitik copper mine, enhancing tailings storage, water recycling, and real-time monitoring to support a safer, more efficient expansion of one of Europe’s key tailings facilities. This investment strengthens Boliden’s push toward zero-harm, standards-aligned tailings management, underscoring how operational scaling at Aitik is being tied closely to tighter environmental controls and more sustainable copper...
OM:SAND
OM:SANDMachinery

Sandvik (OM:SAND) Valuation Check After Major Mining Equipment Wins at Eldorado Gold and Northern Star

Sandvik (OM:SAND) has secured two sizeable mining equipment deals, including battery electric vehicles for Eldorado Gold's Lamaque mine and a major underground fleet order from Northern Star Resources, reinforcing demand for its mining solutions. See our latest analysis for Sandvik. These back to back mining wins arrive as Sandvik's share price trades around SEK 295.7, with strong upward momentum reflected in a roughly 47% year to date share price return and a robust multi year total...
OM:BIOG B
OM:BIOG BBiotechs

BioGaia (OM:BIOG B): Reassessing Valuation After Strong Q3 Results and Operational Improvements

BioGaia (OM:BIOG B) just delivered a stronger third quarter, with sales and net income both climbing while the balance sheet stayed debt free. That combination, plus fresh product innovations, gives investors plenty to reassess. See our latest analysis for BioGaia. The share price tells a more cautious story, with a roughly flat 1 year total shareholder return of about minus 2 percent, even as the latest update hints at improving growth momentum and a healthier earnings profile. If BioGaia's...
OM:WALL B
OM:WALL BReal Estate

Does Wallenstam’s (OM:WALL B) Sergelskrapan Upgrade Reveal a Shift in Its Office Strategy?

Zengun announced that it has signed a partnering agreement with Wallenstam to renovate the landmark Sergelskrapan in central Stockholm, a 21-storey, approximately 16,000-square-metre Hotorget property that Wallenstam acquired in 2024. The two-year project, valued at about SEK 380,000,000, aims to preserve the building’s period character while upgrading energy performance and creating modern, sustainable office space. We’ll now examine how this renovation of Sergelskrapan, with its focus on...
OM:SKIS B
OM:SKIS BHospitality

SkiStar (OM:SKIS B) Seasonal Q1 Loss Tests Bullish Long‑Term Earnings Growth Narrative

SkiStar (OM:SKIS B) has kicked off Q1 2026 with total revenue of 240 million SEK and a net loss, excluding extra items, of 395 million SEK, setting the tone for a seasonally soft but closely watched quarter. The company has seen quarterly revenue move from 214.9 million SEK in Q1 2025 to 230.7 million SEK in Q4 2025 and then to 240 million SEK in Q1 2026, while trailing twelve month revenue sits at about 4.7 billion SEK with net income of 570.6 million SEK. This gives investors a clearer read...
OM:BETS B
OM:BETS BHospitality

How Investors Are Reacting To Betsson (OM:BETS B) Expanding Its €40m Share Buyback Program

Earlier in December 2025, Betsson AB repurchased 126,400 of its own series B shares under a Board-approved share buyback program of up to €40 million, running from October 2025 to April 2026 and carried out in line with EU regulations. Following these transactions, Betsson held 2,154,922 series B and 2,747,433 series C shares, underscoring an active capital management approach aimed at reinforcing its market position and potential shareholder value. We’ll now look at how Betsson’s €40...
OM:BHG
OM:BHGSpecialty Retail

European Stocks Priced Below Estimated Intrinsic Value

As European markets navigate a mixed landscape with the pan-European STOXX Europe 600 Index ending slightly lower, investors are keenly observing economic indicators and central bank policies that could influence future growth. In this environment, identifying stocks priced below their estimated intrinsic value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.
OM:YUBICO
OM:YUBICOSoftware

3 European Growth Companies With Up To 36% Insider Ownership

As the European market navigates a mixed landscape with slight fluctuations in major indices and potential policy shifts by the European Central Bank, investors are keenly observing growth opportunities within the region. In this context, stocks with significant insider ownership often signal strong confidence from those intimately familiar with company operations, making them an intriguing focus for those seeking to understand potential growth trajectories amidst current economic conditions.